Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC.
第一作者:
Biagio,Ricciuti
第一单位:
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
作者:
DOI
10.1016/j.jtocrr.2020.100074
PMID
34589955
发布时间
2023-01-15
- 浏览0

JTO clinical and research reports
2020年1卷4期
100074页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文